Approval · Notice of Compliance 37807 · 2026
HYDROXYCHLOROQUINE: Notice of Compliance 37807
Issued June 30, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37807
- Date
- June 30, 2026
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Update to labelling to matchen licensor
- Canadian reference product
- PLAQUENAL (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDROXYCHLOROQUINE | Not yet assigned | — |
Medicinal ingredients
- HYDROXYCHLOROQUINE SULFATE 200 MG per TAB